Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's Disease
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's Disease
批准号:
10624460
负责人:
Brian C. Kraemer
金额:
$78.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-05-01 至 2027-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We are applying to renew the University of Washington Alzheimer's Disease Training Program (ADTP),
“Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's Disease.” Our program focuses on
translational research in Alzheimer's disease (AD) and related dementias. The objective of our research training
program is to provide interdisciplinary training for basic science, clinical, and translational researchers so that
they will be able to advance both clinical and mechanistic hypotheses about the etiology, pathophysiology, and
treatment of AD and related disorders. Our training program remains the only formal program at the University
of Washington (UW) focused on training investigators to carry out basic mechanistic, clinical, and translational
research in AD and related neurodegenerative dementing disorders.
Our program is supported by the rich and interactive research environment of the UW and Veterans Affairs
Puget Sound Health Care System, where a critical mass of faculty conduct research across the spectrum of AD
and related dementias. The program requests funding to maintain the currently funded positions for 7
postdoctoral trainees and 4 predoctoral students. Postdoctoral PhD candidates come from a broad range of
disciplines, including clinical psychology, neuropsychology, biochemistry, genetics, neurobiology, and
pharmacology. Basic science trainees typically join the program during their first year of postgraduate training
and remain for three years. Incoming MD postdoctoral candidates are expected to have completed a residency,
usually in psychiatry, neurology, neuropathology, radiology, nuclear medicine, internal medicine, or geriatric
medicine. MD and clinician PhD fellows are expected to remain for a two-year period and will be strongly
encouraged to remain for a third year. Predoctoral trainees will be recruited from the following UW PhD programs:
The Medical Scientist Training Program, Genome Sciences, Molecular Basis of Disease, Molecular and Cellular
Biology, Neuroscience, and Pharmacology programs; recruited predoctoral trainees will join the ADTP program
in their second or third year of graduate training. Direct recruitment efforts are made to include underserved
minority trainees.
期刊论文(37)
专著(0)
科研奖励(0)
会议论文
SPOP drives neurodegenerative tauopathy
-
批准号:10734807
-
项目类别:
-
资助金额:$182.34万
-
财政年份:2023
-
负责人:Brian C. Kraemer
-
依托单位:
Targeting MSUT2 with small molecules to ameliorate pathological tau
-
批准号:10735826
-
项目类别:
-
资助金额:$218.13万
-
财政年份:2023
-
负责人:Brian C. Kraemer
-
依托单位:
Formation of Tau RNA Complexes disrupts tau function and drives tau neuropathology
-
批准号:10777174
-
项目类别:
-
资助金额:$63.88万
-
财政年份:2023
-
负责人:Brian C. Kraemer
-
依托单位:
Developing MSUT2 Nanobodies for Targeting Pathological Tau in Alzheimer's Disease
-
批准号:10518408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Brian C. Kraemer
-
依托单位:
Developing MSUT2 Nanobodies for Targeting Pathological Tau in Alzheimer's Disease
-
批准号:10363866
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Brian C. Kraemer
-
依托单位:
Reversal of Tau Pathology with MSUT2 siRNA Conjugates
-
批准号:10240452
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2020
-
负责人:Brian C. Kraemer
-
依托单位:
Reversal of Tau Pathology with MSUT2 siRNA Conjugates
-
批准号:9909831
-
项目类别:
-
资助金额:$21.3万
-
财政年份:2020
-
负责人:Brian C. Kraemer
-
依托单位:
Protection from pathological tau by activation of the ER unfolded protein response
-
批准号:10347310
-
项目类别:
-
资助金额:$52.0万
-
财政年份:2020
-
负责人:Brian C. Kraemer
-
依托单位:
Protection from pathological tau by activation of the ER unfolded protein response
-
批准号:10551219
-
项目类别:
-
资助金额:$52.0万
-
财政年份:2020
-
负责人:Brian C. Kraemer
-
依托单位:
Protection from pathological tau by activation of the ER unfolded protein response
-
批准号:9901055
-
项目类别:
-
资助金额:$53.0万
-
财政年份:2020
-
负责人:Brian C. Kraemer
-
依托单位:
Inhibiting pathological TDP-43 phosphorylation as a therapeutic strategy for ALS
-
批准号:9348132
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Brian C. Kraemer
-
依托单位:
Inhibiting pathological TDP-43 phosphorylation as a therapeutic strategy for ALS
-
批准号:9898277
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Brian C. Kraemer
-
依托单位:
MSUT2 modulates pathological tau in AD and model organisms
-
批准号:9285130
-
项目类别:
-
资助金额:$317.4万
-
财政年份:2017
-
负责人:Brian C. Kraemer
-
依托单位:
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's Disease
-
批准号:10410126
-
项目类别:
-
资助金额:$76.58万
-
财政年份:2016
-
负责人:Brian C. Kraemer
-
依托单位:
Acquisition of a ProteinSimple capillary electrophoresis protein immunoanalyzer
-
批准号:8949379
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Brian C. Kraemer
-
依托单位:
Unfolded protein response activation protects neurons against pathological tau
-
批准号:9064862
-
项目类别:
-
资助金额:$17.58万
-
财政年份:2015
-
负责人:Brian C. Kraemer
-
依托单位:
Identifying new tau targeted therapeutics: a drug repurposing approach
-
批准号:9275429
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Brian C. Kraemer
-
依托单位:
Identifying new tau targeted therapeutics: a drug repurposing approach
-
批准号:8994167
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Brian C. Kraemer
-
依托单位:
Identifying new tau targeted therapeutics: a drug repurposing approach
-
批准号:8815851
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Brian C. Kraemer
-
依托单位:
MSUT2/SUT2 controls tau protein aggregation and neurotoxicity.
-
批准号:8198359
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Brian C. Kraemer
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: